SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-280212
Filing Date
2023-11-20
Accepted
2023-11-20 07:01:00
Documents
13
Period of Report
2023-11-20
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d620464d8k.htm   iXBRL 8-K 28247
2 EX-99.1 d620464dex991.htm EX-99.1 19046
  Complete submission text file 0001193125-23-280212.txt   177154

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pstv-20231120.xsd EX-101.SCH 2879
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20231120_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20231120_pre.xml EX-101.PRE 11281
7 EXTRACTED XBRL INSTANCE DOCUMENT d620464d8k_htm.xml XML 3389
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

IRS No.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 231420694
SIC: 3841 Surgical & Medical Instruments & Apparatus